ABBOTT LABORATORIES — Director's Dealing 2017

Dec 8, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-12-06

Reporting Person: WHITE MILES D (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-06	Common shares without par value	S	103	$54.915	Disposed	3158454	Direct
2017-12-06	Common shares without par value	S	3300	$54.92	Disposed	3155154	Direct
2017-12-06	Common shares without par value	S	392	$54.925	Disposed	3154762	Direct
2017-12-06	Common shares without par value	S	1600	$54.93	Disposed	3153162	Direct
2017-12-06	Common shares without par value	S	1200	$54.94	Disposed	3151962	Direct
2017-12-06	Common shares without par value	S	200	$54.945	Disposed	3151762	Direct
2017-12-06	Common shares without par value	S	428	$54.95	Disposed	3151334	Direct
2017-12-06	Common shares without par value	S	3	$54.955	Disposed	3151331	Direct
2017-12-06	Common shares without par value	S	400	$54.96	Disposed	3150931	Direct
2017-12-06	Common shares without par value	S	100	$54.965	Disposed	3150831	Direct
2017-12-06	Common shares without par value	S	1199	$54.97	Disposed	3149632	Direct
2017-12-06	Common shares without par value	S	200	$54.975	Disposed	3149432	Direct
2017-12-06	Common shares without par value	S	615	$54.98	Disposed	3148817	Direct
2017-12-06	Common shares without par value	S	600	$54.99	Disposed	3148217	Direct
2017-12-06	Common shares without par value	S	100	$55	Disposed	3148117	Direct
2017-12-06	Common shares without par value	S	204	$55.02	Disposed	3148022	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	31675	Indirect
Common shares without par value	9498	Indirect
Common shares without par value	9512	Indirect

Footnotes

F1: Includes shares acquired by the Judith S. White Living Trust under the Abbott Laboratories Dividend Reinvestment and Share Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of December 6, 2017.

F3: The reporting person disclaims beneficial ownership of all securities held by his son.